Search results for "From ACP Internist"
AGA clinical practice update offers guidance on PPI deprescribing
All patients taking a proton-pump inhibitor (PPI) should have a regular review and documentation of ongoing indications for use, which should be the responsibility of the primary care clinician, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/02/25/6.htm
25 Feb 2022
Food insecurity associated with less weight loss, even with intense intervention
The findings of a recent randomized trial suggest that weight loss approaches need to address both obesity and food insecurity, both of which continue to increase in the U.S.
https://gastroenterology.acponline.org/archives/2021/03/26/6.htm
26 Mar 2021
Financial incentives associated with increased FIT uptake but not increased CRC screening overall
A three-arm trial of incentives for fecal immunochemical testing (FIT) and colorectal cancer screening (CRC) tested mail-only, mail and monetary, and mail and lottery interventions.
https://gastroenterology.acponline.org/archives/2019/07/26/7.htm
26 Jul 2019
A new approach to diverticulitis
Evidence is fueling new guidelines suggesting internists treat most cases of uncomplicated diverticulitis in an outpatient setting, without antibiotics.
https://gastroenterology.acponline.org/archives/2022/04/22/8.htm
22 Apr 2022
USPSTF draft recommendations favor screening younger patients for colorectal cancer
The U.S. Preventive Services Task Force (USPSTF) newly issued a B recommendation in support of screening adults ages 45 to 49 years. The recommendations are currently open for public comment.
https://gastroenterology.acponline.org/archives/2020/11/20/6.htm
20 Nov 2020
Guideline suggests prescription medications when lifestyle change ineffective for weight loss
For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://gastroenterology.acponline.org/archives/2022/10/28/6.htm
28 Oct 2022
Get comfortable talking about obesity
In this month's Pearls from I.M. Peers, a new video feature from ACP Internist, Kimberly N. Sims, MD, FACP, explained ways to make obesity counseling easier for patients and for their doctors.
https://gastroenterology.acponline.org/archives/2022/04/22/9.htm
22 Apr 2022
Colonoscopies often recommended to patients with limited life expectancy
A study of patients ages 65 years and older found that 58.1% of those with life expectancy of less than five years and no polyps or only small hyperplastic polyps were told to return for future surveillance, as were 74.8% of those with life expectancy of five to 10 years.
https://gastroenterology.acponline.org/archives/2023/03/24/7.htm
24 Mar 2023
Task Force lowers age for colorectal cancer screening to begin
The U.S. Preventive Services Task Force recommended colorectal cancer screening begin at age 45 years based on an evidence review finding with moderate certainty that the net benefit is moderate to substantial.
https://gastroenterology.acponline.org/archives/2021/05/28/7.htm
28 May 2021
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://gastroenterology.acponline.org/archives/2023/01/27/7.htm
27 Jan 2023